AGILENT TECHNOLOGIES, INC. Proceeds from Sale of Notes Receivable
AGILENT TECHNOLOGIES, INC. (A) reported Proceeds from Sale of Notes Receivable of $2.00 million for the 12-month period ending 2025-10-31, per its 10-K filed 2025-12-22.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfNotesReceivable · last filed 2025-12-22
- AGILENT TECHNOLOGIES, INC. proceeds from sale of notes receivable for fiscal 2025 was $2.00M.
- AGILENT TECHNOLOGIES, INC. proceeds from sale of notes receivable for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- AGILENT TECHNOLOGIES, INC. proceeds from sale of notes receivable for fiscal 2023 was $4.00M.
| Period end | Proceeds from Sale of Notes Receivable 12 month |
|---|---|
| 2025-10-31 | $2.00M 10-K · filed 2025-12-22 |
| 2024-10-31 | $0.00 10-K · filed 2025-12-22 |
| 2023-10-31 | $4.00M 10-K · filed 2025-12-22 |
| 2022-10-31 | $0.00 8-K · filed 2025-03-03 |
| 2021-10-31 | $0.00 8-K · filed 2024-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |